Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Baxter Healthcare Corporation MDS Pharma Services |
---|---|
Information provided by: | Baxter Healthcare Corporation |
ClinicalTrials.gov Identifier: | NCT00508495 |
The aim of the study is to evaluate the therapeutic efficacy, safety and local tolerability of two different paracetamol-containing solutions in postoperative total hip replacement. They will be compared to placebo (a dummy treatment which contains no active ingredient).
Condition | Intervention | Phase |
---|---|---|
Pain, Postoperative |
Drug: Paracetamol (acetaminophen) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Single-Dose Comparison of the Analgesic Efficacy, Safety and Tolerability of Two Paracetamol 1%-Containing Solutions and Placebo in a Post-Surgical Total Hip Replacement Model |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | R-01270-A016, EudraCT 2006-004075-36 |
Study First Received: | July 26, 2007 |
Last Updated: | August 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00508495 |
Health Authority: | Hungary: National Institute of Pharmacy |
pain, postoperative replacement, total hip total hip replacement arthroplasty, replacement, hip |
Signs and Symptoms Postoperative Complications Pain Acetaminophen Pain, Postoperative |
Pathologic Processes Sensory System Agents Analgesics, Non-Narcotic Therapeutic Uses Physiological Effects of Drugs |
Peripheral Nervous System Agents Analgesics Central Nervous System Agents Pharmacologic Actions |